130 related articles for article (PubMed ID: 38151103)
1. Impact of carrier particle surface properties on drug nanoparticle attachment.
Bergillos-Ruiz M; Kumar A; Hodnett BK; Davern P; Rasmuson Å; Hudson SP
Int J Pharm; 2024 Feb; 651():123743. PubMed ID: 38151103
[TBL] [Abstract][Full Text] [Related]
2. Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties.
Kumar A; Hodnett BK; Hudson S; Davern P
Colloids Surf B Biointerfaces; 2020 Sep; 193():111120. PubMed ID: 32505995
[TBL] [Abstract][Full Text] [Related]
3. Carrier particle mediated stabilization and isolation of valsartan nanoparticles.
Kumar A; Davern P; Hodnett BK; Hudson SP
Colloids Surf B Biointerfaces; 2019 Mar; 175():554-563. PubMed ID: 30579056
[TBL] [Abstract][Full Text] [Related]
4. Carrier particle design for stabilization and isolation of drug nanoparticles.
Tierney T; Bodnár K; Rasmuson Å; Hudson S
Int J Pharm; 2017 Feb; 518(1-2):111-118. PubMed ID: 27884714
[TBL] [Abstract][Full Text] [Related]
5. Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.
Azad M; Moreno J; Bilgili E; Davé R
Int J Pharm; 2016 Nov; 513(1-2):319-331. PubMed ID: 27639622
[TBL] [Abstract][Full Text] [Related]
6. Targeted intracellular delivery of hydrophobic agents using mesoporous hybrid silica nanoparticles as carrier systems.
Rosenholm JM; Peuhu E; Eriksson JE; Sahlgren C; Lindén M
Nano Lett; 2009 Sep; 9(9):3308-11. PubMed ID: 19736973
[TBL] [Abstract][Full Text] [Related]
7. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
8. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
[TBL] [Abstract][Full Text] [Related]
9. Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier.
Oh DH; Kang JH; Kim DW; Lee BJ; Kim JO; Yong CS; Choi HG
Int J Pharm; 2011 Nov; 420(2):412-8. PubMed ID: 21944892
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.
Persano F; Batasheva S; Fakhrullina G; Gigli G; Leporatti S; Fakhrullin R
J Mater Chem B; 2021 Mar; 9(12):2756-2784. PubMed ID: 33596293
[TBL] [Abstract][Full Text] [Related]
11. Ball milling synthesis of silica nanoparticle from rice husk ash for drug delivery application.
Salavati-Niasari M; Javidi J; Dadkhah M
Comb Chem High Throughput Screen; 2013 Jul; 16(6):458-62. PubMed ID: 22931308
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
13. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
14. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
15. Impact of altered hydrophobicity and reduced agglomeration on dissolution of micronized poorly water-soluble drug powders after dry coating.
Kim S; Bilgili E; Davé RN
Int J Pharm; 2021 Sep; 606():120853. PubMed ID: 34252519
[TBL] [Abstract][Full Text] [Related]
16. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
[TBL] [Abstract][Full Text] [Related]
18. Preparation, stabilisation, isolation and tableting of valsartan nanoparticles using a semi-continuous carrier particle mediated process.
Kumar A; Ramisetty KA; Bordignon S; Hodnett BK; Davern P; Hudson S
Int J Pharm; 2021 Mar; 597():120199. PubMed ID: 33486046
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant properties of probucol released from mesoporous silica.
Lau M; Giri K; Garcia-Bennett AE
Eur J Pharm Sci; 2019 Oct; 138():105038. PubMed ID: 31398394
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
